ArticleIntensive care medicine2022

Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.

Stefan Hagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.